We thank Drs Sehgal and Ramsden for their interest in our review. It was not our intention to address the theoretical basis for attempts to control blood pressure but to review the evidence regarding clinical efficacy. The authors are correct in saying that the effects on cerebral perfusion of administered therapies for hypotension may be important, but these effects are almost completely unstudied. Our own research suggests that some hypotensive, very preterm babies can still autoregulate and probably others cannot; however how this can be determined in clinical practice, and how this should affect treatment decisions, is unknown.
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Alterations in loading conditions of the heart and how they impact cardiac performance are also important issues outside the scope of our systematic review, but we agree that further afterloading of an already compromised myocardium is unlikely to be beneficial to its performance.
In the same spirit of critical review, there is little objective evidence in the literature that using functional echocardiography to determine cardiac performance and individualize therapy actually improves the outcomes. Even if we personally believe that this is likely to be true, we will need better evidence that the babies benefit from bedside functional echocardiography in order to change neonatal training and practice and for the resources required to be committed.
